While many of the invasive and metastatic properties of EphA2 are attributed to ligand-independent signaling [7, 15, 19, 20] ephrin A1-mediated ligand activation of EphA2 is generally antagonistic in action, leading to cell repulsion and tumor suppression [18, 19, 21–23]. This evidence concerns the gene EPHA2 and neoplasm.